|    Jul 2017

DAB project recieved funding via a MIT R&D Program

DAB has secured funding from an MIT R&D Program to further develop its novel bioreactor technology.

The project was selected via a tender process and five companies, including DAB received a voucher, from minister Kamp and depute Bom-Lemstra of the province of South-Holland. The subsidy supports collaboration between Wageningen University and DAB.

DAB has developed a robust, patented, bioreactor technology that overcomes many of the pitfalls of industrial fermentation through the combination of fermentation and separation into a single vessel, enabling in-situ product recovery without any moving parts or membranes.

To find out more about the MIT R&D Programs – click here.

To find out more about Wageningen University – click here.